Organon & Co.
As of Oct 15, 2026 close
- Market cap
- $3.72B
- P/E (TTM)
- 17.81
- Forward P/E
- 34.70
- Dividend yield
- 0.58%
- 52-week range
- $5.69$13.83
- Volume (live)
- -
- Avg. volume (3M)
- 2.33M
Organon & Co. (OGN) Stock Price & Financial Analysis
Organon & Co. Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $13.75 - $13.77 |
|---|---|
| 52-Week High | $13.83 |
| 52-Week Low | $5.69 |
| Open | $13.75 |
| Volume (last close) | 1.98M |
| Average Volume (3M) | 2.33M |
| Revenue (TTM) | 6.13B |
|---|---|
| Net Income (TTM) | 209.00M |
| Free Cash Flow (TTM) | 567.00M |
| EPS (TTM) | $0.79 |
| Profit Margin | 3.41% |
| Operating Margin | 18.79% |
| Return on Equity (ROE) | 20.78% |
| Debt to Equity | 8.50 |
| Annual Dividend | $0.08 |
|---|---|
| Dividend Yield | 0.58% |
| Payout Ratio | 10.09% |
| Last Dividend Ex-Date | Aug 14, 2026 |
| Market Cap | 3.72B |
|---|---|
| Shares Outstanding | 270.45M |
| P/E Ratio (TTM) | 17.81 |
| Forward P/E | 34.70 |
| Price to Sales (P/S) | 0.61 |
| Price to Book (P/B) | 3.70 |
| EV/EBITDA | 8.86 |
| 50-Day MA | $13.71 |
|---|---|
| 200-Day MA | $11.16 |
| 1-Year Change | +46.70% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Organon & Co. at a Glance
As of the Oct 15, 2026 close, Organon & Co. (OGN) has a market capitalization of $3.72B. The stock trades at 17.8× trailing earnings, 34.7× forward earnings and 0.6× sales. Over the trailing twelve months it earned $209.00M on revenue of $6.13B (a 3.4% profit margin) and generated $567.00M of free cash flow. Revenue fell 2.5% year over year.
As of its latest reported balance sheet, it holds $1.13B in cash and securities against $8.55B of debt, a net debt position of $7.42B.
Organon & Co. pays a quarterly dividend totaling $0.08 per share a year, a 0.58% yield at the Oct 15, 2026 close, with a 10% payout ratio.
The share price is up 46.7% over the past year. At $13.76 (the Oct 15, 2026 close) it sits near the top of its 52-week range of $5.69 to $13.83, above its 200-day moving average of $11.16.
Frequently Asked Questions About Organon & Co.
What is the current stock price for OGN?
As of the Oct 15, 2026 close, OGN stock trades at $13.76. The 52-week range is $5.69–$13.83, with a day range of $13.75–$13.77.
What is the P/E ratio for OGN?
As of the Oct 15, 2026 close, Organon & Co.'s trailing twelve-month (TTM) P/E ratio is 17.8, meaning investors pay $17.8 for every $1 of annual earnings. The forward P/E is 34.7, reflecting analyst expectations for future earnings. Organon & Co. operates in the Healthcare sector.
Does OGN pay dividends?
Yes, Organon & Co. pays a 0.58% annual dividend yield as of the Oct 15, 2026 close ($0.08 per share a year). The trailing twelve-month payout ratio is 10.1%. The most recent ex-dividend date was August 14, 2026.
What do analysts recommend for OGN?
Analyst ratings and recommendations for OGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of OGN?
As of the Oct 15, 2026 close, Organon & Co.'s market capitalization is $3.72B, classifying it as a mid-cap company. Organon & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.